Article Text

Download PDFPDF
Cochrane systematic review
No current evidence that routine administration of oxygen to people with acute myocardial infarction improves pain or mortality; further conclusive trials are needed
  1. Nathan Mewton1,
  2. Kihei Yoneyama2
  1. 1Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, Bron, France
  2. 2Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki-City, Kanagawa, Japan
  1. Correspondence to Nathan Mewton
    Centre d'Investigation Clinique, 28 Avenue Doyen Lépine, 69500 Bron, France; nmewton{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on:


Nothing much remains of the treatments and strategies that were applied 25 years ago in the clinical setting of an acute myocardial infarction (AMI). One of the few remaining treatments is oxygen therapy. This oxygen therapy is employed in a reflexive and ‘emergency-department based’ empirical manner as a reaction to a life-threatening situation. Oxygen therapy is still recommended in several international guidelines for the treatment of uncomplicated AMI, but this ‘reasonable’ recommendation has no true scientific background.1 2 It is to the credit of Cabello and colleagues to have explored the evidence or rather, in this case, the absence of evidence for the clinical effects of oxygen therapy at the acute phase of myocardial infarction.


In this study, Cabello and colleagues performed an extensive and thorough review of the literature, retrieving all randomised …

View Full Text


  • Competing interests None.